Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Intuitive SurgicalEdwards LifesciencesAlign TechnologyZimmer BiometColoplast A/S
SymbolNASDAQ:ISRGNYSE:EWNASDAQ:ALGNNYSE:ZBHOTCMKTS:CLPBY
Price Information
Current Price$812.57$89.02$606.33$171.88$16.15
52 Week RangeHoldBuyBuyBuyHold
MarketRank™
Overall Score1.71.41.92.11.0
Analysis Score2.21.32.32.50.0
Community Score2.93.02.82.82.2
Dividend Score0.00.00.01.71.7
Ownership Score1.71.71.71.70.0
Earnings & Valuation Score1.91.32.51.91.3
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price Target$750.94$91.16$502.17$167.86N/A
% Upside from Price Target-7.58% downside2.40% upside-17.18% downside-2.34% downsideN/A
Trade Information
Market Cap$96.19 billion$55.37 billion$47.98 billion$35.81 billion$34.88 billion
Beta0.980.971.681.340.28
Average Volume572,7792,641,993626,7981,241,521106,713
Sales & Book Value
Annual Revenue$4.48 billion$4.35 billion$2.41 billion$7.98 billion$2.76 billion
Price / Sales21.4812.7419.944.4912.63
Cashflow$12.14 per share$2.03 per share$6.64 per share$15.90 per share$0.31 per share
Price / Cash66.9643.9091.2910.8152.47
Book Value$71.43 per share$6.63 per share$17.08 per share$60.25 per share$0.48 per share
Price / Book11.3813.4335.502.8533.65
Profitability
Net Income$1.38 billion$1.05 billion$442.78 million$1.13 billion$585.21 million
EPS$9.95$1.86$4.96$7.87$0.30
Trailing P/E Ratio92.5571.2227.591,074.3257.68
Forward P/E Ratio78.4341.7985.1621.7644.86
P/E Growth8.962.614.074.32N/A
Net Margins24.45%18.18%76.00%0.52%21.62%
Return on Equity (ROE)12.08%29.00%68.99%10.07%69.30%
Return on Assets (ROA)10.44%18.10%46.64%4.93%33.77%
Dividend
Annual PayoutN/AN/AN/A$0.96$0.22
Dividend YieldN/AN/AN/A0.56%1.36%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A12.20%73.33%
Years of Consecutive Dividend GrowthN/AN/AN/A1 YearsN/A
Debt
Debt-to-Equity RatioN/A0.14%N/A0.67%0.02%
Current Ratio7.04%3.52%1.31%2.18%1.29%
Quick Ratio6.30%2.61%1.20%1.02%0.90%
Ownership Information
Institutional Ownership Percentage86.50%80.94%85.84%87.17%0.10%
Insider Ownership Percentage1.60%1.48%1.20%0.44%N/A
Miscellaneous
Employees8,08114,90018,07019,90012,500
Shares Outstanding118.38 million622.04 million79.14 million208.32 million2.16 billion
Next Earnings Date4/20/2021 (Confirmed)4/20/2021 (Confirmed)4/28/2021 (Confirmed)5/4/2021 (Confirmed)N/A
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Expands By 75.8%Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Expands By 75.8%
americanbankingnews.com - April 17 at 1:58 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 14Coloplast A/S - Transactions in connection with share buy-back programme, week 14
finance.yahoo.com - April 12 at 7:18 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 13Coloplast A/S - Transactions in connection with share buy-back programme, week 13
finance.yahoo.com - April 6 at 8:20 AM
Coloplast A/S (OTCMKTS:CLPBY) Receives Consensus Rating of "Hold" from BrokeragesColoplast A/S (OTCMKTS:CLPBY) Receives Consensus Rating of "Hold" from Brokerages
americanbankingnews.com - April 1 at 12:52 PM
Coloplast A/S (OTCMKTS:CLPBY) Short Interest UpdateColoplast A/S (OTCMKTS:CLPBY) Short Interest Update
americanbankingnews.com - March 30 at 11:24 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 12Coloplast A/S - Transactions in connection with share buy-back programme, week 12
finance.yahoo.com - March 29 at 6:09 AM
Coloplast awarded Ostomy Products contract with VizientColoplast awarded Ostomy Products contract with Vizient
finance.yahoo.com - March 29 at 6:09 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 11Coloplast A/S - Transactions in connection with share buy-back programme, week 11
finance.yahoo.com - March 22 at 10:15 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 10Coloplast A/S - Transactions in connection with share buy-back programme, week 10
finance.yahoo.com - March 15 at 8:59 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 9Coloplast A/S - Transactions in connection with share buy-back programme, week 9
finance.yahoo.com - March 8 at 9:48 AM
Coloplast A/S - Transactions in connection with share buy-back programme, week 8Coloplast A/S - Transactions in connection with share buy-back programme, week 8
finance.yahoo.com - March 1 at 11:26 AM
Coloplast A/S to Host Earnings CallColoplast A/S to Host Earnings Call
finance.yahoo.com - February 2 at 2:59 PM
Coloplast A/S - Announcement no. 01/2021 – Interim Financial Report, Q1 2020/21Coloplast A/S - Announcement no. 01/2021 – Interim Financial Report, Q1 2020/21
finance.yahoo.com - February 2 at 9:58 AM
Coloplast delivers a good start to the year with 5% organic growth in Q1 and maintains its financial guidance for 2020/21Coloplast delivers a good start to the year with 5% organic growth in Q1 and maintains its financial guidance for 2020/21
finance.yahoo.com - February 2 at 9:58 AM
Coloplast A/S - Allocation of Share OptionsColoplast A/S - Allocation of Share Options
finance.yahoo.com - January 22 at 1:21 PM
Coloplast A/S ADR CLPBYColoplast A/S ADR CLPBY
morningstar.com - December 27 at 12:59 AM
Coloplast A/S ADRColoplast A/S ADR
wsj.com - December 18 at 11:46 PM
Coloplast A/S - Announcement no. 14/2020 - Decisions of Annual General Meeting 2020Coloplast A/S - Announcement no. 14/2020 - Decisions of Annual General Meeting 2020
finance.yahoo.com - December 3 at 4:58 PM
Coloplast A/S - Announcement no. 15/2020 - Articles of AssociationColoplast A/S - Announcement no. 15/2020 - Articles of Association
finance.yahoo.com - December 3 at 4:58 PM
Coloplast A/S - Announcement no. 13/2020 - Notice of Annual General MeetingColoplast A/S - Announcement no. 13/2020 - Notice of Annual General Meeting
finance.yahoo.com - November 10 at 9:24 AM
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated personsColoplast A/S - Trading in Coloplast shares by board members, executives or associated persons
finance.yahoo.com - November 5 at 10:04 AM
Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20
finance.yahoo.com - November 3 at 9:43 AM
Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
finance.yahoo.com - November 3 at 9:43 AM
Coloplast acquires Nine Continents Medical, Inc.Coloplast acquires Nine Continents Medical, Inc.
finance.yahoo.com - November 3 at 9:43 AM
Coloplast A/S - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20Coloplast A/S - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20
finance.yahoo.com - November 3 at 9:43 AM
DateCompanyBrokerageAction
4/1/2021Intuitive SurgicalCitigroupInitiated Coverage
4/1/2021Intuitive SurgicalCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated Coverage
3/31/2021Intuitive SurgicalPiper SandlerBoost Price Target
1/22/2021Intuitive SurgicalJPMorgan Chase & Co.Boost Price Target
1/22/2021Intuitive SurgicalRaymond JamesBoost Price Target
1/22/2021Intuitive SurgicalWells Fargo & CompanyBoost Price Target
1/22/2021Intuitive SurgicalOppenheimerBoost Price Target
12/15/2020Intuitive SurgicalMorgan StanleyDowngrade
10/16/2020Intuitive SurgicalSVB LeerinkBoost Price Target
10/16/2020Intuitive SurgicalStifel NicolausBoost Price Target
10/15/2020Intuitive SurgicalBTIG ResearchReiterated Rating
9/28/2020Intuitive SurgicalArgusInitiated Coverage
9/11/2020Intuitive SurgicalWolfe ResearchInitiated Coverage
9/8/2020Intuitive SurgicalBank of AmericaDowngrade
9/1/2020Intuitive SurgicalRobert W. BairdInitiated Coverage
4/15/2021Edwards LifesciencesAtlantic SecuritiesInitiated Coverage
4/5/2021Edwards LifesciencesEvercore ISIUpgrade
12/16/2020Edwards LifesciencesSmith Barney CitigroupDowngrade
12/11/2020Edwards LifesciencesCanaccord GenuityBoost Price Target
12/7/2020Edwards LifesciencesCredit Suisse GroupBoost Price Target
10/27/2020Edwards LifesciencesJefferies Financial GroupBoost Price Target
10/19/2020Edwards LifesciencesCowenBoost Price Target
2/4/2021Align TechnologyBarclaysBoost Price Target
11/24/2020Align TechnologyThe Goldman Sachs GroupBoost Price Target
7/29/2020Align TechnologyBerenberg BankDowngrade
4/15/2021Zimmer BiometNorthland SecuritiesUpgrade
2/8/2021Zimmer BiometDeutsche Bank AktiengesellschaftBoost Price Target
2/5/2021Zimmer BiometNeedham & Company LLCBoost Price Target
1/27/2021Zimmer BiometJMP SecuritiesBoost Price Target
1/6/2021Zimmer BiometTruist FinancialBoost Price Target
3/9/2021Coloplast A/SCommerzbankUpgrade
8/11/2020Coloplast A/SNordea Equity ResearchDowngrade
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.